中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2010
Turn off MathJax
Article Contents

Recent status and prospect of ascites treatment in cirrhosis patients

  • Published Date: 2010-06-20
  • Ascites is the most common complication in cirrhosis, and is closely related to the increased mortality due to infection, diluted hyponatremia and renal failure.Rest and sodium restriction are the components of the managements of uncomplicated mild ascites.Low dose diuretics are effective in patients with moderate ascites.Furthermore, the large-volume paracentesis (LVP) with albumin administration (8 g/L of ascites removed) are the treatment of choice for the management of patients with large ascites.As to the refractory ascites, methods for treatment include repeated LVP with plasma expander or transjugular intrahepatic portosystemic shunt (TIPS) .New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis.

     

  • loading
  • [1]Planas R, Montoliu S, Balleste'B, et al.Natural history of patients hospitalized for management of cirrhotic ascites[J].Clin Gastroenterol Hepatol, 2006, 4 (11) ∶1385-1394.
    [2]Gine`s P.Vaptans:a promising therapy in the management of advanced cirrhosis[J].J Hepatol, 2007, 46 (6) ∶1150-1152.
    [3]Moore KP, Wong F, Gine`s P, et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club[J].Hepatology, 2003, 38 (1) ∶258-266.
    [4]Santos J, Planas R, Pardo A, et al.Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis:a randomized comparative study of efficacy and safety[J].J Hepatol, 2003, 39 (2) ∶187-192.
    [5]Li CP, Lee FY, Hwang SJ, et al.Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis:a randomized crossover study[J].Am J Gastroenterol, 2000, 95 (4) ∶1051-1055.
    [6]Lee FY, Lee SD, Tsai YT, et al.A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps[J].J Hepatol, 1991, 12 (2) ∶236-240.
    [7]Angeli P, Albino G, Carraro P, et al.Cirrhosis and muscle cramps:evidence of a causal relationship[J].Hepatology, 1996, 23 (2) ∶264-273.
    [8]Ruiz-del-Arbol L, Monescillo A, Jimeénez W, et al.Paracentesis-induced circulatory dysfunction:mechanism and effect on hepatic hemodynamics in cirrhosis[J].Gastroenterology, 1997, 113 (2) ∶579-586.
    [9]Runyon BA.Management of adult patients with ascites due to cirrhosis[J].Hepatology, 2004, 39 (3) ∶841-856.
    [10]Sakai H, Sheer TA, Mendler MH, et al.Choosing the location for non-image guided abdominal paracentesis[J].Liver Int, 2005, 25 (5) ∶984-986.
    [11]Moore KP, Aithal GP.Guidelines on the management of ascites in cirrhosis[J].Gut, 2006, 55 (Suppl6) ∶vi1-vi12.
    [12]Moore KP, Wong F, Gine`s P, et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club[J].Hepatology, 2003, 38 (1) ∶258-266.
    [13]Boyer TD, Haskal Z.The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension[J].Hepatology, 2005, 41 (2) ∶386-400.
    [14]Gine`s P, Uriz J, Calahorra B, et al.Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].Gastroenterology, 2002, 123 (6) ∶18391847.
    [15]Salerno F, Camma C, Enea M, et al.Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data[J].Gastroenterology, 2007, 133 (3) ∶825834.
    [16]Fernandez-Varo G, Ros J, Cejudo-Martin P, et al.Effect of the V1a/V2-AVP receptor antagonist, conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites[J].J Hepatol, 2003, 38 (6) ∶755-761.
    [17]Wong F, Gine`s P, Watson HR, et al.Effects of a selective vasopressin V2receptor antagonist, satavaptan (SR121463B) , on recurrence of ascites after large volume paracentesis[J].Hepatology, 2006, 44 (2) ∶s270.
    [18]Kalambokis G, Fotopoulos A, Economou M, et al.Effects of a7day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites[J].J Hepatol, 2007, 46 (2) ∶213-221.
    [19]Lenaerts A, Codden T, Meunier JC, et al.Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system[J].Hepatology, 2006, 44 (4) ∶844849.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (668) PDF downloads(454) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return